These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28584711)

  • 1. Quercetin reduces hydroxyurea induced cytotoxicity in immortalized mouse aortic endothelial cells.
    Kiser ZM; McGee MDM; Wright RJ; Quarshie A; Newman GW; Randall KR; Stiles JK; Driss A; Hibbert JM
    PeerJ; 2017; 5():e3376. PubMed ID: 28584711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anti-angiogenic effects of hydroxyurea.
    Lopes FC; Ferreira R; Albuquerque DM; Silveira AA; Costa R; Soares R; Costa FF; Conran N
    Microvasc Res; 2014 Jul; 94():106-13. PubMed ID: 24925859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hydroxyurea and ET
    Taylor C; Kasztan M; Tao B; Pollock JS; Pollock DM
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13178. PubMed ID: 30144292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory Potential of Quercetin-3-O-β-D-("2"-galloyl)-glucopyranoside and Quercetin Isolated from Diospyros kaki calyx via Suppression of MAP Signaling Molecules in LPS-induced RAW 264.7 Macrophages.
    Cho YH; Kim NH; Khan I; Yu JM; Jung HG; Kim HH; Jang JY; Kim HJ; Kim DI; Kwak JH; Kang SC; An BJ
    J Food Sci; 2016 Oct; 81(10):C2447-C2456. PubMed ID: 27648736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea (hydroxycarbamide) genotoxicity in pediatric patients with sickle cell disease.
    Rodriguez A; Duez P; Dedeken L; Cotton F; Ferster A
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27022. PubMed ID: 29512872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Attenuates Manganese-Induced Neuroinflammation by Alleviating Oxidative Stress through Regulation of Apoptosis, iNOS/NF-κB and HO-1/Nrf2 Pathways.
    Bahar E; Kim JY; Yoon H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.
    Smaldone A; Findley S; Bakken S; Matiz LA; Rosenthal SL; Jia H; Matos S; Manwani D; Green NS
    Contemp Clin Trials; 2016 Jul; 49():134-42. PubMed ID: 27327779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid Deposition.
    Xue F; Nie X; Shi J; Liu Q; Wang Z; Li X; Zhou J; Su J; Xue M; Chen WD; Wang YD
    Front Pharmacol; 2017; 8():40. PubMed ID: 28217098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy.
    Saleh AW; Hillen HF; Duits AJ
    Acta Haematol; 1999; 102(1):31-7. PubMed ID: 10473885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Almeida CB; Souza LE; Leonardo FC; Costa FT; Werneck CC; Covas DT; Costa FF; Conran N
    Blood; 2015 Aug; 126(6):711-20. PubMed ID: 26019278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease.
    Morris CR; Vichinsky EP; van Warmerdam J; Machado L; Kepka-Lenhart D; Morris SM; Kuypers FA
    J Pediatr Hematol Oncol; 2003 Aug; 25(8):629-34. PubMed ID: 12902916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
    Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
    Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher oxygen saturation with hydroxyurea in paediatric sickle cell disease.
    van Geyzel L; Arigliani M; Inusa B; Singh B; Kozlowska W; Chakravorty S; Bossley CJ; Ruiz G; Rees D; Gupta A
    Arch Dis Child; 2020 Jun; 105(6):575-579. PubMed ID: 31871045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
    Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
    Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
    Tavakkoli F; Nahavandi M; Wyche MQ; Castro O
    Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.